Close-up of a scientist holding a tray of petri dishes with purple cultures, wearing gloves and safety gear.

Our

Process

Empowering research and investment to shape tomorrow’s medicine

Phase one

Discovery
and Assessment

The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project’s innovation, potential impact, and feasibility.

This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.

Scientist using a multi-channel pipette to transfer liquid samples in a lab, wearing gloves and surrounded by lab equipment.

Phase two

Due Diligence and
Selection

Following initial assessments, selected projects undergo a comprehensive due diligence process. This step digs deeper into the project's technical details, team qualifications, legal considerations, and financial requirements. It ensures that only the most viable and impactful projects are chosen for funding, aligning with Stem's mission to accelerate the development of transformative healthcare solutions.

Silhouette of a researcher examining a slide under a microscope with a blue background.

Phase three

Matching with Investors

Once a project passes our stringent evaluation process, Stem matches it with suitable investors from our network. This matchmaking is based on the project's specific needs and the investor's interest areas and investment philosophy.

Our aim is to create synergistic partnerships that provide not just financial support but also strategic value to propel the research forward.

A man in a white lab coat working at a computer, viewing a 3D model on the screen in a laboratory or office setting.

Vancouver, BC V6H 3P6

2026 GDP3

Available only to qualified purchasers, accredited investors, and other eligible persons where permitted by applicable law. The information contained on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any security, investment product, or advisory service. Any such offer will be made only pursuant to definitive offering documents and in compliance with applicable securities laws. Certain investments involve risk, including the possible loss of principal, are illiquid, and may not be suitable for all investors. Past performance is not indicative of future results. © 2026 GDP³ Capital Partners.

Vancouver, BC V6H 3P6

2026 GDP3

Available only to qualified purchasers, accredited investors, and other eligible persons where permitted by applicable law. The information contained on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any security, investment product, or advisory service. Any such offer will be made only pursuant to definitive offering documents and in compliance with applicable securities laws. Certain investments involve risk, including the possible loss of principal, are illiquid, and may not be suitable for all investors. Past performance is not indicative of future results. © 2026 GDP³ Capital Partners.

Vancouver, BC V6H 3P6

2026 GDP3

Available only to qualified purchasers, accredited investors, and other eligible persons where permitted by applicable law. The information contained on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any security, investment product, or advisory service. Any such offer will be made only pursuant to definitive offering documents and in compliance with applicable securities laws. Certain investments involve risk, including the possible loss of principal, are illiquid, and may not be suitable for all investors. Past performance is not indicative of future results. © 2026 GDP³ Capital Partners.